The US pharmaceutical concern Pfizer has received patents on two new drugs. The Indian authorities have approved a patent for the Prevenar 13 vaccine against pneumococcal infection, which is the leading cause of child deaths under the age of five. At the same time, the US Food and Drug Administration (FDA) approved a new Pfizer leukemia drug, called Besponsa, which is four times more effective than the standard medical treatments.
The new drugs’ releases will undoubtedly increase the company's profits, which will positively affect the shares’ value. Due to the positive news, Pfizer shares have already risen by 1.19% and continue to grow, which gives an excellent opportunity to make money. Trading will be available during the American session from 13:40 to 20:00 GMT time.
The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions